Yellow Fever Vaccine Market Report 2025 (Global Edition)

Global Yellow Fever Vaccine Market Report 2025 Market Size Split by Transmission Type (Sylvatic Yellow Fever, Intermediate Yellow Fever, Urban Yellow Fever), by Treatment Type (Vaccines, Medications, ...

Yellow Fever Vaccine Market Report Description

We have various report editions of Yellow Fever Vaccine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Yellow Fever Vaccine Market Insights Video

Competitive Landscape of the Yellow Fever Vaccine Market

In the Yellow Fever Vaccine market's competitive landscape, numerous key competitors are driving innovation and growth. With increasing demand for vaccines and the need to respond to outbreaks rapidly, manufacturers are investing in R&D to improve production efficiency and vaccine efficacy. Collaboration between vaccine manufacturers and global organizations, such as the World Health Organization (WHO), Gavi, and UNICEF, is a critical aspect of the competitive landscape.

Top Companies Market Share in Yellow Fever Vaccine Industry: (In no particular order of Rank)

• Takeda Pharmaceutical Company Ltd
• Merck & Co. Inc
• GlaxoSmithKline PLC
• Biological E Limited
• Panacea Biotec
• iBio Inc
• FSUE Chumakov
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Yellow Fever Vaccine Market

Which Region Dominates the Yellow Fever Vaccine Market in 2024?

According to Cognitive Market Research, North America currently dominates the Yellow Fever Vaccine market, and the region is expected to have significant growth during the projected period. Governments in North America, especially the U.S. Centers for Disease Control and Prevention (CDC) and Health Canada have actively promoted yellow fever vaccination for travelers, boosting market demand. In Canada, the yellow fever vaccine is available exclusively at vaccination centers designated by the Public Health Agency of Canada (PHAC). Out of more than 540 million doses administered globally, only 23 cases of vaccine failure have been documented. Sixteen of these cases occurred within 10 years of vaccination, while one occurred 20 years later, and another at 27 years post-vaccination. The U.S. also has specialized travel health clinics authorized to provide the vaccine, ensuring easy access for travelers.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The yellow fever vaccine market in the region has been expanding due to factors such as population growth, lifestyle changes, and increased consumption of unhealthy foods. According to the Global Food Policy Report 2024: Food Systems for Healthy Diets and Nutrition, 38% of the Indian population consumes unhealthy foods, while only 28% meet the recommended intake of all five food groups—starchy staples, vegetables, fruits, pulses or nuts, and animal-source foods. This growing trend of poor dietary habits, combined with population growth, increases vulnerability to diseases and weakens immune defenses, creating a greater need for preventative healthcare measures, including vaccinations like the yellow fever vaccine. The rise in government-led health initiatives and the improvement of healthcare infrastructure across the region further support market growth. Governments are becoming more proactive in promoting immunization campaigns, particularly for diseases like yellow fever that pose significant risks to travelers and local populations in endemic zones.

The current report Scope analyzes Yellow Fever Vaccine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Yellow Fever Vaccine Market Analysis

According to Cognitive Market Research, the global Yellow Fever Vaccine market size was estimated at USD 4528.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1811.40 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Yellow Fever Vaccine market with a market size of USD 1429.19 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. In the U.S., the demand for the Yellow Fever Vaccine market is driven by the increased international travel from endemic regions.
• The Canada Yellow Fever Vaccine market had a market share of USD 217.37 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. In Canada, the demand for the Yellow Fever Vaccine market is driven by the heightened awareness of yellow fever risks among healthcare providers and the public.
• The Mexico Yellow Fever Vaccine market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 164.84 million in 2024.

Europe Yellow Fever Vaccine Market Analysis

According to Cognitive Market Research, the global Yellow Fever Vaccine market size was estimated at USD 4528.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1358.55 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031.

• The United Kingdom Yellow Fever Vaccine market had a market share of USD 228.24 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. In the UK, the demand for the Yellow Fever Vaccine Market is driven by the availability of vaccination services through specialized travel clinics and healthcare providers.
• The France Yellow Fever Vaccine market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 124.99 million in 2024.
• According to Cognitive Market Research, the German Yellow Fever Vaccine market size was valued at USD 268.99 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. In Germany, the demand for the Yellow Fever Vaccine Market is driven by the country's public health policies, which emphasize the importance of vaccinations for travelers, and also play a significant role in promoting vaccine uptake.
• The Italy Yellow Fever Vaccine market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD 116.84 million in 2024.
• The Russian Yellow Fever Vaccine market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 210.58 million in 2024.
• The Spain Yellow Fever Vaccine market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 111.40 million in 2024
• The Luxembourg Yellow Fever Vaccine market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 42.12 million in 2024.
• The Portugal Yellow Fever Vaccine market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 28.53 million in 2024.
• The Greece Yellow Fever Vaccine market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 16.30 million in 2024.
• The Rest of Europe's Yellow Fever Vaccine market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 210.58 million in 2024.

Asia Pacific Yellow Fever Vaccine Market Analysis

According to Cognitive Market Research, the global Yellow Fever Vaccine market size was estimated at USD 4528.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1041.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Yellow Fever Vaccine market size was valued at USD 468.70 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. In China, the demand for the Yellow Fever Vaccine market is driven by Government regulations requiring proof of vaccination for travelers returning from Africa and South America regions.
• The Japan Yellow Fever Vaccine market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 143.73 million in 2024.
• The India Yellow Fever Vaccine market had a market share of USD 124.99 million in 2024 and is projected to grow at a CAGR of 9.3% during the forecast period. India's growing emphasis on preventive healthcare, and the government's commitment to strengthening immunization programs to enhance public health safety, driving market growth.
• The South Korean Yellow Fever Vaccine market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 104.16 million in 2024.
• The Australian Yellow Fever Vaccine market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 54.16 million in 2024.
• The South East Asia Yellow Fever Vaccine market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 71.87 million in 2024.
• The Rest of Asia Pacific Yellow Fever Vaccine market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 73.95 million in 2024.

South America Yellow Fever Vaccine Market Analysis

According to Cognitive Market Research, the global Yellow Fever Vaccine market size was estimated at USD 4528.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 226.43 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Yellow Fever Vaccine market size was valued at USD 96.91 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. In Brazil, the demand for the Yellow Fever Vaccine market is driven by the country's endemic status for yellow fever and recurrent outbreaks that necessitate widespread vaccination efforts.
• Argentina's Yellow Fever Vaccine market had a market share of USD 38.04 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. In Argentina, the demand for the Yellow Fever Vaccine market is driven by the government's vaccination campaigns aim to immunize at-risk populations, especially in rural and forested areas where the disease is prevalent.
• Colombia Yellow Fever Vaccine market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 20.15 million in 2024.
• Peru Yellow Fever Vaccine market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 18.57 million in 2024.
• Chile's Yellow Fever Vaccine market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 16.30 million in 2024.
• The Rest of Latin America's Yellow Fever Vaccine market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 36.45 million in 2024.

Middle East Yellow Fever Vaccine Market Analysis

According to Cognitive Market Research, the global Yellow Fever Vaccine market size was estimated at USD 4528.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 90.57 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

• The GCC Countries Yellow Fever Vaccine market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 38.76 million in 2024. Power Generator sales flourish due to the region's growing tourism sector, particularly in cities like Dubai, increasing awareness of health risks associated with international travel.
• The Egypt Yellow Fever Vaccine market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 9.51 million in 2024.
• The South Africa Yellow Fever Vaccine market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 14.31 in 2024. In South Africa, the demand for the Yellow Fever Vaccine Market is driven by the periodic outbreaks of yellow fever in neighboring regions, which raise public health concerns and awareness.
• The Turkey Yellow Fever Vaccine market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 7.79 million in 2024.
• The Nigeria Yellow Fever Vaccine market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 9.51 million in 2024.
• The Rest of the MEA Yellow Fever Vaccine market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 10.69 million in 2024.

Yellow Fever Vaccine Market Analysis

Yellow Fever Vaccine Market Transmission Type Segment Analysis

According to Cognitive Market Research, Sylvatic Yellow Fever is likely to dominate the Yellow Fever Vaccine Market over the forecast period. Sylvatic yellow fever is transmitted in forested regions where the virus is maintained in a cycle between non-human primates (such as monkeys) and mosquitoes, particularly Aedes species. As urban areas expand and encroach on forested zones, human populations increasingly come into contact with sylvatic (jungle) ecosystems. This closer interaction with natural reservoirs of yellow fever heightens the risk of spillover into human populations, thereby increasing the demand for vaccination in regions where sylvatic transmission occurs.

Urban Yellow Fever is the fastest-growing segment in the Yellow Fever Vaccine Market. As urban areas grow, they become densely populated, creating ideal conditions for the transmission of diseases like yellow fever. The movement of people into cities, particularly in endemic regions in Africa and South America, enhances the risk of yellow fever outbreaks. Urban environments often provide suitable breeding grounds for Aedes aegypti mosquitoes, which are the primary vectors of urban yellow fever. These mosquitoes thrive in stagnant water found in urban settings, such as in discarded containers, flower pots, and other water-collecting surfaces.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Yellow Fever Vaccine Industry. Request a Free Sample PDF!

Yellow Fever Vaccine Market Treatment Type Segment Analysis

According to Cognitive Market Research, The Vaccines segment holds the largest market share. Many countries have implemented policies requiring yellow fever vaccination for travelers to endemic areas. These regulations create a consistent demand for vaccines among travelers and populations in affected regions. Initiatives led by organizations such as the World Health Organization (WHO) and Gavi, the Vaccine Alliance, focus on increasing vaccination coverage, particularly in endemic areas. Such support includes funding for vaccine procurement and distribution.

In the Yellow Fever Vaccine market, the rapidly growing sector is the Medications category. While the yellow fever vaccine is the primary means of prevention, supportive care medications (e.g., analgesics, antipyretics, and fluids) are crucial for managing symptoms in infected individuals. The need for these medications becomes particularly vital in severe cases, driving growth in this segment. Healthcare providers are increasingly implementing comprehensive treatment protocols that combine vaccination with supportive medications, which enhances patient outcomes and increases the market for these medications.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Yellow Fever Vaccine Application Segment Analysis

Yellow Fever Vaccine Market End-Use Segment Analysis

According to Cognitive Market Research, The Hospitals segment holds the largest market share. Many hospitals now feature specialized travel health clinics that provide vaccinations for travelers heading to endemic areas. This service is driving demand for yellow fever vaccines as travelers often require proof of vaccination for entry into certain countries. Hospitals are increasingly integrating vaccination into broader patient care strategies, including routine immunizations for children and adults. This integration helps promote yellow fever vaccination as part of a comprehensive health program.

In the Yellow Fever Vaccine market, The Community Health Centers segment holds the largest market share. Community health centers are often strategically located in underserved areas, making healthcare services, including vaccinations, more accessible to populations that might otherwise face barriers. This is crucial in rural and urban areas with limited healthcare infrastructure. Many countries have integrated yellow fever vaccination into their national immunization schedules, utilizing CHCs to deliver these vaccines. This formal inclusion ensures a steady demand for vaccines.

• Hospitals
• Clinics
• Community Health Centers
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion